ATE164590T1 - Aminosäurederivat und bromacetyl-modifizierte peptide - Google Patents

Aminosäurederivat und bromacetyl-modifizierte peptide

Info

Publication number
ATE164590T1
ATE164590T1 AT92913815T AT92913815T ATE164590T1 AT E164590 T1 ATE164590 T1 AT E164590T1 AT 92913815 T AT92913815 T AT 92913815T AT 92913815 T AT92913815 T AT 92913815T AT E164590 T1 ATE164590 T1 AT E164590T1
Authority
AT
Austria
Prior art keywords
peptide
bbal
peptides
polymers
amino acid
Prior art date
Application number
AT92913815T
Other languages
English (en)
Inventor
John K Inman
Frank A Robey
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE164590T1 publication Critical patent/ATE164590T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT92913815T 1991-06-14 1992-06-10 Aminosäurederivat und bromacetyl-modifizierte peptide ATE164590T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/715,650 US5286846A (en) 1991-06-14 1991-06-14 Amino acid derivative and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides

Publications (1)

Publication Number Publication Date
ATE164590T1 true ATE164590T1 (de) 1998-04-15

Family

ID=24874927

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92913815T ATE164590T1 (de) 1991-06-14 1992-06-10 Aminosäurederivat und bromacetyl-modifizierte peptide

Country Status (7)

Country Link
US (2) US5286846A (de)
EP (1) EP0590038B1 (de)
AT (1) ATE164590T1 (de)
AU (1) AU666858B2 (de)
CA (1) CA2111465A1 (de)
DE (1) DE69224988D1 (de)
WO (1) WO1992022318A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117974A (en) * 1991-10-02 2000-09-12 Peptor Limited Libraries of backbone-cyclized peptidomimetics
JP3712261B2 (ja) * 1992-04-07 2005-11-02 ザ スクリップス リサーチ インスティテュート 修飾タンパク質の製造方法
DE69508382D1 (de) * 1994-01-19 1999-04-22 Us Health Peptomere mit erhöhter immunogenizität
AU7569796A (en) * 1995-11-21 1997-06-11 Glycotech Corp. Multivalent polymers, processes for their preparation, and their use for preparing biologically active compounds.
US6759509B1 (en) * 1996-11-05 2004-07-06 Bristol-Myers Squibb Company Branched peptide linkers
ES2268776T3 (es) * 1997-04-18 2007-03-16 Novartis Ag Neoglicoproteinas.
US5908783A (en) * 1997-12-04 1999-06-01 Southern University, Bd. Of Trustee Alternating lysine-alanine copolymer substrate for promoting neuron survival and axon growth
AU2001252978A1 (en) * 2000-03-27 2001-10-08 Zyomyx, Inc. Site-specific, covalent bioconjugation of proteins
AU2002303259A1 (en) * 2001-04-06 2002-10-21 Chiron Corporation Peptides incorporating chemoselective functionalities
WO2003062290A1 (en) 2002-01-16 2003-07-31 Biocompatibles Uk Limited Polymer conjugates
GB0301014D0 (en) * 2003-01-16 2003-02-19 Biocompatibles Ltd Conjugation reactions
IL156263A0 (en) * 2003-06-02 2004-01-04 Hadasit Med Res Service Livin-derived peptides, compositions and uses thereof
WO2005039641A2 (en) * 2003-10-15 2005-05-06 The Regents Of The University Of California Biomacromolecule polymer conjugates
US8658180B2 (en) 2008-08-15 2014-02-25 Mark A. Miller Vaccines against influenza virus
IL199618A0 (en) 2009-06-29 2010-04-29 Two To Biotech Ltd Novel antibodies and their use in diagnostic methods
IL200202A0 (en) 2009-08-02 2010-05-31 Orly Devary Novel proteins
US11173199B2 (en) 2019-11-13 2021-11-16 Alopexx Inc. Low contaminant compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59164797A (ja) * 1983-03-09 1984-09-17 Wakunaga Seiyaku Kk タンパク誘導体およびその製造法
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides

Also Published As

Publication number Publication date
US5286846A (en) 1994-02-15
EP0590038B1 (de) 1998-04-01
US5444150A (en) 1995-08-22
CA2111465A1 (en) 1992-12-23
EP0590038A1 (de) 1994-04-06
AU666858B2 (en) 1996-02-29
AU2179892A (en) 1993-01-12
DE69224988D1 (de) 1998-05-07
WO1992022318A1 (en) 1992-12-23
EP0590038A4 (en) 1994-08-24

Similar Documents

Publication Publication Date Title
ATE164590T1 (de) Aminosäurederivat und bromacetyl-modifizierte peptide
Robey et al. Automated synthesis of N-bromoacetyl-modified peptides for the preparation of synthetic peptide polymers, peptide-protein conjugates, and cyclic peptides
FI94419C (fi) Menetelmä terapeuttisesti käyttökelpoisen membraaniankkuri-vaikuttava-ainekonjugaatin valmistamiseksi
US5066716A (en) Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
US6174530B1 (en) Homogeneous polyoxime compositions and their preparation by parallel assembly
US6001364A (en) Hetero-polyoxime compounds and their preparation by parallel assembly
BRPI0417744A (pt) métodos para conjugar um imunogene de peptìdeo e para induzir uma resposta imune em um indivìduo mamìfero, conjugado de portador de peptìdeo de imunogene-proteìna/polipeptìdeo e composição imunogênica
Tuchscherer Template assembled synthetic proteins: condensation of a multifunctional peptide to a topological template via chemoselective ligation
BRPI0417689A (pt) método para conjugar um imonógeno de peptìdeo, composição, conjugado, composição imunogênica, método para induzir uma resposta imune em um indivìduo mamìfero, e, uso do conjugado
FI943591A7 (fi) Synteettinen hemofilus-influenssa yhdistelmärokote
CY1108570T1 (el) Gd3-μιμητικα πεπτιδια
EP0861264A2 (de) Kollagenaehnliche strukturen, die peptoidreste enthalten
Lahiri et al. Total chemical synthesis of an integral membrane enzyme: diacylglycerol kinase from Escherichia coli
JPH06510028A (ja) ランチオニン架橋ペプチド
AU2007278407B2 (en) Protein-binding methotrexate derivatives, and medicaments containing the same
AR131494A1 (es) Vehículos de conjugación a base de proteína
AU5008785A (en) Process for synthesising peptides
BR0113439A (pt) Processo para a manufatura de um imunógeno para vacina, derivado de maleimida de peptìdeo de ige, uso do mesmo, conjugado adequado para uso em uma vacina e composição de vacina
EP0468714A2 (de) Peptid-Polysaccharid-Protein-Konjugat als Impfstoff
US5041533A (en) Hinge peptide, a process for its manufacture, and its use for the manufacture of synthetic immunogens
WO1994018233A1 (en) Thymosin alpha-1 derivatives
WO2017101786A1 (zh) 一种多肽化合物及其制备方法与应用
DavidáPallin Assembly of cyclic peptide dendrimers from unprotected linear building blocks in aqueous solution
JPH04243896A (ja) 環状のhiv主要中和決定基ペプチド
Zamuner et al. Insertion of a flexible spacer increases the yield of site-specific bioconjugation through N-terminal transamination